SHH · 603439.SS
GuiZhou SanLi Pharmaceutical Co.,Ltd
CN¥10.61-CN¥0.13 (-1.21%)
GuiZhou SanLi Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 39.23% below the high.
Loading market information…
SHZ · 300942.SZ · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:04 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Shenzhen Bioeasy Biotechnology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 50.52% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Shenzhen Bioeasy Biotechnology Co., Ltd.’s forward annual dividend is CN¥0.02 per share, paid annual. The forward yield is 0.43% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Shenzhen Bioeasy Biotechnology Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Founded in 2007 and headquartered in Shenzhen, China, Shenzhen Bioeasy Biotechnology Co., Ltd. specializes in the development and commercialization of rapid testing instruments and reagents throughout the Chinese market. The company's comprehensive diagnostic equipment addresses a wide array of applications, spanning food and agricultural analysis, dairy, meat, and aquatic product testing, honey quality control, drug detection, public safety measures, and clinical diagnostics.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:39 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥10.61-CN¥0.13 (-1.21%)
GuiZhou SanLi Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 39.23% below the high.
CN¥13.00-CN¥0.20 (-1.52%)
Beijing Scitop Bio-tech Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 51.99% below the high.
CN¥16.58-CN¥0.19 (-1.13%)
Hvsen Biotechnology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 49.17% below the high.
CN¥9.16-CN¥0.01 (-0.11%)
Pulike Biological Engineering, Inc.’s quoted price sits in the lower half of its reported 52-week range, 37.17% below the high.
CN¥7.00-CN¥0.16 (-2.23%)
Shanghai Shen Lian Biomedical Corporation’s quoted price sits in the lower half of its reported 52-week range, 38.86% below the high.
CN¥10.26-CN¥0.12 (-1.16%)
Guanhao Biotech Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.0% below the high.
CN¥18.05-CN¥0.52 (-2.8%)
Lifecome Biochemistry Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 62.95% below the high.
CN¥15.53-CN¥0.32 (-2.02%)
Beijing Kawin Technology Share-Holding Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 47.07% below the high.
